PCM
KITE

Prelude Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Prelude Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,500
Closed -$270K – 1965
2017
Q3 		$270K Buy
+1,500
New +$209K 0.02% 551

Prelude Capital Management's KITE Position: Q4 2017 in Review

Prelude Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 44,779 shares — an estimated $8.05M sold.

Prelude Capital Management first reported a position in KITE in Q3 2016 and held it in 5 quarters. The position peaked at $8.05M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Prelude Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Prelude Capital Management sold 44,779 Kite Pharma, Inc. shares in Q4 2017, an estimated $8.05M.
  • Prelude Capital Management first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 5 quarters.
  • Prelude Capital Management's Kite Pharma, Inc. position peaked at $8.05M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.